mexiletine has been researched along with Cardiac Complex, Premature in 86 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty two patients with ventricular extrasystole (VES) after myocardial infarction had been treated with antiarrhythmic drugs in the half (41 patients) with mexiletine (M) and in the half (41 patients) with other ones." | 9.07 | [Long-term mexiletine treatment of ventricular arrhythmia in patients after myocardial infarction]. ( Axenti, I; Drazkiewicz, U; Olszowy, Z; Petelenz, T, 1992) |
| "In a controlled randomized cross-over trial, 21 patients with coronary artery disease and frequent ventricular arrhythmias were studied to test the efficacy and tolerance of mexiletine 200 mg t." | 9.06 | [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine]. ( Geibel, A; Hohnloser, S; Hust, M; Just, H; Meinertz, T; Zehender, M, 1987) |
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 9.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "The antiarrhythmic effects of the sustained release form of mexiletine (Mexitil-Perlongets) were evaluated in a double-blind placebo trial in 630 patients with recent documented myocardial infarction." | 9.05 | International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group. ( , 1984) |
| "Twenty-four patients with ventricular arrhythmias were treated with oral mexiletine for periods of from one to 16 months (total 10." | 9.04 | Long-term treatment of ventricular arrhythmias with oral mexiletine. ( Julian, DG; Prescott, LF; Talbot, RG, 1976) |
| "Fifty-four patients with a symptomatic ventricular arrhythmia underwent two 24-hour electrocardiographic recordings, respectively before and after two to three weeks treatment with mexiletine, at a dose of 200 mg three times a day." | 7.67 | Effectiveness of mexiletine in ventricular arrhythmias. ( Chaudron, JM; Luwaert, RJ, 1985) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 7.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "We studied the antiarrhythmic effect of oral Mexiletine in 20 patients with stable high-frequency ventricular arrhythmias refractory to therapeutic doses of conventional antiarrhythmic therapy." | 7.66 | [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)]. ( Affinito, V; Ansalone, G; Bellocci, F; Loperfido, F; Lucente, M; Santarelli, P; Scabbia, E; Zecchi, P, 1981) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 7.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| "Oral mexiletine was begun immediately after completion of the intravenous infusion at a dose of 10 mg/kg/24 hr in the 10 responders to intravenous therapy." | 6.66 | Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia. ( Frye, SJ; Greenspan, AM; Horowitz, LN; Lowenthal, DT; Spielman, SR; Yacone, LA, 1985) |
| "In Mexiletine treated group the following results have been obtained: 19 excellent (76%), 4 good (16%) and 2 ineffective (8%)." | 6.65 | [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias]. ( Bonatti, V; Botti, G; Favaro, L; Finardi, A; Rolli, A, 1981) |
| " However, the pharmacokinetic interaction between mexiletine and theophylline has not been clarified." | 5.28 | [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma]. ( Hariya, Y; Hayakawa, H; Inafuku, M; Nagasawa, K; Nakahara, Y; Ohtsu, F; Suzuki, T; Yoshioka, Y, 1992) |
| "In four children the first signs of arrhythmias were seen a short time after viral infection." | 5.26 | [Mexiletine in the treatment of ventricular arrhythmias (author's transl)]. ( Schlemmer, M; Wimmer, M, 1982) |
| "Eighty two patients with ventricular extrasystole (VES) after myocardial infarction had been treated with antiarrhythmic drugs in the half (41 patients) with mexiletine (M) and in the half (41 patients) with other ones." | 5.07 | [Long-term mexiletine treatment of ventricular arrhythmia in patients after myocardial infarction]. ( Axenti, I; Drazkiewicz, U; Olszowy, Z; Petelenz, T, 1992) |
| "In a controlled randomized cross-over trial, 21 patients with coronary artery disease and frequent ventricular arrhythmias were studied to test the efficacy and tolerance of mexiletine 200 mg t." | 5.06 | [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine]. ( Geibel, A; Hohnloser, S; Hust, M; Just, H; Meinertz, T; Zehender, M, 1987) |
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 5.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "The antiarrhythmic effects of the sustained release form of mexiletine (Mexitil-Perlongets) were evaluated in a double-blind placebo trial in 630 patients with recent documented myocardial infarction." | 5.05 | International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group. ( , 1984) |
| "Twenty-four patients with ventricular arrhythmias were treated with oral mexiletine for periods of from one to 16 months (total 10." | 5.04 | Long-term treatment of ventricular arrhythmias with oral mexiletine. ( Julian, DG; Prescott, LF; Talbot, RG, 1976) |
| "Mexiletine is a type I antiarrhythmic drug that is structurally similar to lidocaine." | 3.76 | Mexiletine: a new type I antiarrhythmic agent. ( Bauman, JL; Schrader, BJ, 1986) |
| "The electrophysiological effects of combination therapy of mexiletine and propafenone were assessed using standard 12-lead electrocardiogram (standard ECG), signal-averaged ECG (SAECG), and ambulatory ECG in 31 patients with ventricular arrhythmias." | 3.68 | Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy. ( Haruna, M; Kato, H; Lee, S; Machii, T; Nonokawa, M; Takanaka, C; Yabe, S, 1992) |
| " In patients refractory to amiodarone alone or to a combination with mexiletine, the combined treatment with amiodarone and class-I-C drugs such as flecainide and encainide prolongs the cycle length of ventricular tachycardia, but does not suppress induction of ventricular tachycardia during programmed stimulation." | 3.68 | [Combination anti-arrhythmic drug therapy]. ( Jung, W; Lüderitz, B; Manz, M, 1992) |
| "Fifty-four patients with a symptomatic ventricular arrhythmia underwent two 24-hour electrocardiographic recordings, respectively before and after two to three weeks treatment with mexiletine, at a dose of 200 mg three times a day." | 3.67 | Effectiveness of mexiletine in ventricular arrhythmias. ( Chaudron, JM; Luwaert, RJ, 1985) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 3.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "We studied the antiarrhythmic effect of oral Mexiletine in 20 patients with stable high-frequency ventricular arrhythmias refractory to therapeutic doses of conventional antiarrhythmic therapy." | 3.66 | [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)]. ( Affinito, V; Ansalone, G; Bellocci, F; Loperfido, F; Lucente, M; Santarelli, P; Scabbia, E; Zecchi, P, 1981) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 3.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| "Flecainide was superior to mexiletine in overall PVC reduction (p less than 0." | 2.67 | A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes. ( Balducelli, M; Boriani, G; Capucci, A; Carini, G; Carozzi, A; Di Pasquale, G; Finzi, A; Frabetti, L; Magnani, B; Pinelli, G, 1991) |
| " The study confirms that long-term use of mexiletine is efficacious and relatively free of cardiac depressant effects even in patients with diminished LV function." | 2.67 | Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia. ( Doherty, P; Eisenberg, B; Hughes, E; Klein, R; Shand, M; Singh, S, 1990) |
| "Disopyramide was effective in 50% of total cases with 44." | 2.67 | Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate. ( Fujino, T; Hara, M; Ishida, S; Ito, M; Maeda, T; Nakagawa, M; Saikawa, T; Shimoyama, N; Takahashi, N; Yonemochi, H, 1992) |
| "Oral mexiletine was begun immediately after completion of the intravenous infusion at a dose of 10 mg/kg/24 hr in the 10 responders to intravenous therapy." | 2.66 | Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia. ( Frye, SJ; Greenspan, AM; Horowitz, LN; Lowenthal, DT; Spielman, SR; Yacone, LA, 1985) |
| " The most frequently used dosage of mexiletine during each 3-month treatment period was 600 mg/day (50." | 2.66 | Chronic mexiletine therapy for suppression of ventricular arrhythmias. ( Duke, M, 1988) |
| "In 16 healthy males bioavailability of Mexicord (Polfa) was studied, in comparison with mexiletine of foreign made." | 2.66 | [Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)]. ( Filipek, M; Koliński, P; Markiewicz, M; Nartowicz, E; Paczkowski, D; Sadowski, Z, 1989) |
| "Mexiletine was statistically more effective (P less than ." | 2.66 | Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia. ( Assey, ME; Hanger, KH; Hudson, WM; Miller, SC, 1985) |
| "In Mexiletine treated group the following results have been obtained: 19 excellent (76%), 4 good (16%) and 2 ineffective (8%)." | 2.65 | [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias]. ( Bonatti, V; Botti, G; Favaro, L; Finardi, A; Rolli, A, 1981) |
| "Sustained ventricular tachyarrhythmias were induced in 12 of the 56 trials of the VSP." | 1.32 | Ventricular tachyarrhythmias in a canine model of LQT3: arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine. ( Aizawa, Y; Chinushi, M; Hosaka, Y; Komura, S; Sugiura, H; Tagawa, M; Washizuka, T, 2003) |
| "When disopyramide or mexiletine were ineffective or not tolerated, the alternative drug was administered and the efficacy was again evaluated." | 1.28 | Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats. ( Hiraoka, M; Motomiya, T; Sakurada, H, 1991) |
| "In 5 patients (71%) ventricular tachycardia was abolished." | 1.28 | Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia. ( Graboys, TB; Lampert, S; Ravid, S, 1991) |
| "The antiarrhythmic effectiveness and safety of 12-h oral administration of mexiletine were evaluated in adult outpatients with a baseline hourly rate of PVCs of 30 or higher who had initially shown at least a 50 percent reduction of this rate when treated with mexiletine at an 8-h dosage interval." | 1.28 | Efficacy of oral mexiletine therapy at a 12-h dosage interval. ( Hughes, EM; MacGregor, TR; Sharon, G; Steen, SN, 1990) |
| " However, the pharmacokinetic interaction between mexiletine and theophylline has not been clarified." | 1.28 | [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma]. ( Hariya, Y; Hayakawa, H; Inafuku, M; Nagasawa, K; Nakahara, Y; Ohtsu, F; Suzuki, T; Yoshioka, Y, 1992) |
| "Ventricular extrasystoles completely regressed after the initial rapid intravenous injection in 7 out of the 12 patients (58,3 p." | 1.26 | [Anti-arrhythmic effects of mexiletine]. ( Besse, P; Favreau, L; Ledain, L; Page, A, 1982) |
| "In four children the first signs of arrhythmias were seen a short time after viral infection." | 1.26 | [Mexiletine in the treatment of ventricular arrhythmias (author's transl)]. ( Schlemmer, M; Wimmer, M, 1982) |
| " In 26 of the 32 patients optimum dosage for maximum beneficial effect appeared to be 200 mg 3 times daily." | 1.26 | [Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)]. ( Esser, H; Kikis, D, 1977) |
| "In 9 cases, the ventricular premature beats were totally or almost totally abolished up to 20 to 100 min." | 1.26 | The efficacy of intravenous mexiletine on ventricular ectopic activity. ( Kulbertus, HE; Waleffe, A, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (70.93) | 18.7374 |
| 1990's | 23 (26.74) | 18.2507 |
| 2000's | 2 (2.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinushi, M | 1 |
| Tagawa, M | 1 |
| Sugiura, H | 1 |
| Komura, S | 1 |
| Hosaka, Y | 1 |
| Washizuka, T | 1 |
| Aizawa, Y | 1 |
| Tian, XL | 1 |
| Cheng, Y | 1 |
| Zhang, T | 1 |
| Liao, ML | 1 |
| Yong, SL | 1 |
| Wang, QK | 1 |
| Theisen, K | 1 |
| Jahrmärker, H | 1 |
| Rozenshtraukh, LV | 1 |
| Aniukhovskiĭ, EP | 1 |
| Beloshapko, GG | 1 |
| Dremin, SA | 1 |
| Kipshidze, NN | 1 |
| Chapidze, GE | 1 |
| Dzhandzhgava, ShM | 1 |
| Ol'binskaia, LI | 1 |
| Iurina, MS | 1 |
| Litvitskiĭ, PF | 1 |
| Sandrikov, VA | 1 |
| Kulikova, AG | 1 |
| Smirnova, OV | 1 |
| Sgammini, H | 1 |
| Evequoz, C | 1 |
| Vera, T | 1 |
| Cengarle, S | 1 |
| Chuit, R | 1 |
| Kuschnir, E | 1 |
| Codecà, L | 1 |
| Gruppillo, P | 1 |
| Padovan, GC | 1 |
| Masoni, C | 1 |
| Masoni, A | 1 |
| Rolli, A | 1 |
| Bonatti, V | 1 |
| Finardi, A | 1 |
| Favaro, L | 1 |
| Botti, G | 1 |
| Bellocci, F | 1 |
| Ansalone, G | 1 |
| Scabbia, E | 1 |
| Santarelli, P | 1 |
| Lucente, M | 1 |
| Affinito, V | 1 |
| Loperfido, F | 1 |
| Zecchi, P | 1 |
| Kurbanov, RD | 1 |
| Mazur, NA | 7 |
| Zacà, F | 1 |
| Cremonesi, A | 1 |
| Pagliarani, PL | 1 |
| Guelfi, P | 1 |
| Bugiardini, R | 1 |
| Lasagna, I | 1 |
| Ghinelli, M | 1 |
| Luciani, G | 1 |
| Mehta, J | 1 |
| Conti, CR | 1 |
| Schlemmer, M | 1 |
| Wimmer, M | 1 |
| Klempt, HW | 1 |
| Nayebagha, A | 1 |
| Fabry, E | 1 |
| Ledain, L | 1 |
| Page, A | 1 |
| Favreau, L | 1 |
| Besse, P | 1 |
| Petelenz, T | 2 |
| Chruściel, TL | 1 |
| Gaszewska, I | 1 |
| Słomińska-Petelenz, T | 1 |
| Elertowicz, M | 1 |
| Grzybek, B | 1 |
| Lüderitz, B | 3 |
| Rudolph, R | 1 |
| Seggewiss, H | 1 |
| Seckfort, H | 1 |
| Richard, M | 1 |
| Touminet, MA | 1 |
| Revillon, L | 1 |
| Pacholke, H | 1 |
| Beck, OA | 1 |
| Hochrein, H | 1 |
| Masotti, G | 2 |
| Morettini, A | 1 |
| Casolo, GC | 1 |
| Ieri, A | 2 |
| Zipoli, A | 1 |
| Serneri, GG | 1 |
| Arakawa, K | 1 |
| Doi, Y | 1 |
| Hashiba, K | 1 |
| Mitsuoka, T | 1 |
| Yanaga, T | 1 |
| Hata, Y | 1 |
| Ogawa, N | 1 |
| Cernusková, L | 1 |
| Benes, L | 1 |
| Csöllei, J | 1 |
| Tumová, I | 1 |
| Svec, P | 1 |
| Zaliunas, R | 1 |
| Zabiela, P | 1 |
| Slapikas, R | 1 |
| Vainoras, A | 1 |
| Pentiokiniene, D | 1 |
| Levisauskiene, R | 1 |
| Bechtold, H | 1 |
| Meyer, U | 1 |
| Komori, S | 1 |
| Sano, S | 1 |
| Li, BH | 1 |
| Matsumura, K | 1 |
| Naitoh, A | 1 |
| Mochizuki, S | 1 |
| Ishihara, T | 2 |
| Watanabe, A | 1 |
| Umetani, K | 1 |
| Ijiri, H | 1 |
| Mondillo, S | 1 |
| Faglia, S | 1 |
| D'Aprile, N | 1 |
| Mangiacotti, L | 1 |
| Campolo, MA | 1 |
| Agricola, E | 1 |
| Palazzuoli, V | 1 |
| Talbot, RG | 1 |
| Julian, DG | 1 |
| Prescott, LF | 1 |
| Pozenel, H | 1 |
| Campbell, NP | 1 |
| Chaturvedi, NC | 1 |
| Shanks, RG | 1 |
| Kelly, JG | 1 |
| Strong, JE | 1 |
| Adgey, AA | 1 |
| Kühn, P | 1 |
| Kroiss, A | 1 |
| Klicpera, M | 1 |
| Zilcher, H | 1 |
| Kaindl, F | 2 |
| Esser, H | 1 |
| Kikis, D | 1 |
| Waleffe, A | 1 |
| Kulbertus, HE | 1 |
| Merx, W | 1 |
| Henning, B | 1 |
| Brunner, H | 1 |
| De Bakker, JM | 1 |
| Härtel, H | 1 |
| Stauch, M | 1 |
| Sigel, H | 1 |
| Steinbach, K | 1 |
| Glogar, D | 1 |
| Weber, H | 1 |
| Kinast, H | 1 |
| Joskowicz, G | 1 |
| Loskot, F | 1 |
| Bauer, U | 1 |
| Liakishev, AA | 1 |
| Podrid, FD | 1 |
| Piotrovskiĭ, VK | 1 |
| Takanaka, C | 1 |
| Nonokawa, M | 1 |
| Machii, T | 1 |
| Lee, S | 1 |
| Kato, H | 1 |
| Haruna, M | 1 |
| Yabe, S | 1 |
| Lombardi, F | 1 |
| Torzillo, D | 1 |
| Sandrone, G | 1 |
| Dalla Vecchia, L | 1 |
| Cappiello, E | 1 |
| Habot, B | 1 |
| Rabinovitz, C | 1 |
| Friedensohn, A | 1 |
| Schlesinger, Z | 1 |
| Baumel, Y | 1 |
| Saikawa, T | 1 |
| Nakagawa, M | 1 |
| Takahashi, N | 1 |
| Ishida, S | 1 |
| Fujino, T | 1 |
| Ito, M | 1 |
| Shimoyama, N | 1 |
| Hara, M | 1 |
| Yonemochi, H | 1 |
| Maeda, T | 1 |
| Jung, W | 1 |
| Manz, M | 2 |
| Inafuku, M | 1 |
| Suzuki, T | 1 |
| Ohtsu, F | 1 |
| Hariya, Y | 1 |
| Nagasawa, K | 1 |
| Yoshioka, Y | 1 |
| Nakahara, Y | 1 |
| Hayakawa, H | 1 |
| Drazkiewicz, U | 1 |
| Axenti, I | 1 |
| Olszowy, Z | 1 |
| Urumbaev, RK | 1 |
| Suprunova, IP | 1 |
| Imanakunova, DSh | 1 |
| Rakhimova, GR | 1 |
| Steen, SN | 1 |
| Hughes, EM | 1 |
| Sharon, G | 1 |
| MacGregor, TR | 1 |
| Ueno, K | 1 |
| Miyai, K | 1 |
| Seki, T | 1 |
| Kawaguchi, Y | 1 |
| Singh, S | 1 |
| Klein, R | 1 |
| Eisenberg, B | 1 |
| Hughes, E | 1 |
| Shand, M | 1 |
| Doherty, P | 1 |
| Zang, Y | 1 |
| Korkushko, OV | 2 |
| Shatilo, VB | 1 |
| Capucci, A | 1 |
| Di Pasquale, G | 1 |
| Boriani, G | 1 |
| Carini, G | 1 |
| Balducelli, M | 1 |
| Frabetti, L | 1 |
| Carozzi, A | 1 |
| Finzi, A | 1 |
| Pinelli, G | 1 |
| Magnani, B | 1 |
| Abdalla, A | 5 |
| Nazarenko, VA | 1 |
| Sakurada, H | 1 |
| Motomiya, T | 1 |
| Hiraoka, M | 1 |
| Fujimoto, Y | 1 |
| Fukuki, M | 1 |
| Hirokane, Y | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Tanabe, T | 2 |
| Takahashi, K | 1 |
| Yoshioka, K | 1 |
| Goto, Y | 2 |
| Ravid, S | 1 |
| Lampert, S | 1 |
| Graboys, TB | 2 |
| Horowitz, LN | 1 |
| Greenspan, AM | 1 |
| Spielman, SR | 1 |
| Frye, SJ | 1 |
| Yacone, LA | 1 |
| Lowenthal, DT | 1 |
| Accettura, D | 2 |
| De Toma, L | 2 |
| Lagioia, R | 2 |
| Mastropasqua, F | 2 |
| Mangini, SG | 2 |
| Scrutinio, D | 2 |
| Rizzon, P | 2 |
| Vitale, P | 1 |
| Agretto, A | 1 |
| Iarussi, D | 1 |
| Perna, B | 1 |
| Romano, A | 1 |
| Casale, D | 1 |
| Porreca, GP | 1 |
| Chaudron, JM | 1 |
| Luwaert, RJ | 1 |
| Podrid, PJ | 1 |
| Schrader, BJ | 1 |
| Bauman, JL | 1 |
| Butenko, AG | 1 |
| Di Taranto, A | 1 |
| De Matteis, D | 1 |
| Wagner, WL | 1 |
| Zehender, M | 1 |
| Geibel, A | 1 |
| Hust, M | 1 |
| Hohnloser, S | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Caiati, C | 1 |
| Carlone, S | 1 |
| Delfino, M | 1 |
| Angelici, E | 1 |
| Teneggi, V | 1 |
| Del Bolgia, F | 1 |
| Serra, P | 1 |
| Duke, M | 1 |
| Hattori, Y | 1 |
| Hidaka, T | 1 |
| Aisaka, K | 1 |
| Satoh, F | 1 |
| Breithaupt, H | 1 |
| Schmidt, A | 1 |
| Patt, MV | 1 |
| Grossbard, CL | 1 |
| Lown, B | 1 |
| Sumarokov, AB | 1 |
| Iavorskaia, NV | 1 |
| Murakawa, Y | 1 |
| Toda, I | 1 |
| Nozaki, A | 1 |
| Kawakubo, K | 1 |
| Sugimoto, T | 1 |
| Poggesi, L | 1 |
| Scarti, L | 1 |
| Lanzetta, T | 1 |
| Grazzini, M | 1 |
| Del Bene, P | 1 |
| Masini, G | 1 |
| Del Citerna, F | 1 |
| Carnovali, M | 1 |
| Orlov, VN | 1 |
| Shpektor, AV | 1 |
| Mamaev, VI | 1 |
| Susliak, NN | 1 |
| Sadowski, Z | 1 |
| Paczkowski, D | 1 |
| Markiewicz, M | 1 |
| Nartowicz, E | 1 |
| Koliński, P | 1 |
| Filipek, M | 1 |
| Aguglia, F | 1 |
| Gnecchi, M | 1 |
| De Marzio, P | 1 |
| Yoshikawa, H | 1 |
| Tagawa, R | 1 |
| Furuya, H | 1 |
| Ide, M | 1 |
| Assey, ME | 1 |
| Hudson, WM | 1 |
| Hanger, KH | 1 |
| Miller, SC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL[NCT01576042] | 27 participants (Actual) | Interventional | 2012-05-31 | Terminated (stopped due to Main objectives of the study were met; consensus among investigators that continuing the study would not add new information beyond that already learned.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Records participants hospitalized for VT during the study (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 7 |
Records participants who completed Month 3 Follow-Up Visit (NCT01576042)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 12 |
Records participants who completed Month 6 Follow-Up Visit (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 7 |
| Antiarrhythmic Medication | 10 |
Records participants who had at least one of the efficacy outcome measurement (including death, hospitalization due to VT) (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who received study randomized treatment during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who only received study treatment as randomized during the entire study (NCT01576042)
Timeframe: 6 month
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 6 |
| Antiarrhythmic Medication | 13 |
Records participants who received study treatment as randomized and later switched to other treatment arm during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 1 |
Days from the date of the first study treatment to the date of first ICD recurrent therapy for VT. (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | Days (Mean) |
|---|---|
| Catheter Ablation | 70.1 |
| Antiarrhythmic Medication | 78.7 |
3 reviews available for mexiletine and Cardiac Complex, Premature
| Article | Year |
|---|---|
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi | 1980 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Comple | 1985 |
Mexiletine: a new type I antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Biotransformation; Cardiac Complexes, Premature; Clinical Trials as | 1986 |
37 trials available for mexiletine and Cardiac Complex, Premature
| Article | Year |
|---|---|
[Clinical study of the anti-arrhythmia preparation, mexitil].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Tr | 1980 |
[Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; Lidocain | 1981 |
[Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; H | 1981 |
Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Diarrhea; Double | 1982 |
[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Electrocardiogr | 1982 |
[Potentiation of an anti-arrhythmia action by the combined use of mexiletine and propranolol].
Topics: Aged; Cardiac Complexes, Premature; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Elec | 1984 |
Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
Topics: Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Complexes, Premature; Clinical Trials as Topic | 1984 |
International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Delayed-A | 1984 |
Signal-averaged ECG in prediction of the short-term suppression of ventricular premature beats by Mexiletine.
Topics: Administration, Oral; Algorithms; Cardiac Complexes, Premature; Delayed-Action Preparations; Electro | 1994 |
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carnitine; Drug Sy | 1995 |
Long-term treatment of ventricular arrhythmias with oral mexiletine.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as T | 1976 |
[Anti-arrhythmia action of mexiletine (KO 1173) on ventricular ectopic arrhythmias in dependence of its serum concentration].
Topics: Cardiac Complexes, Premature; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; H | 1977 |
[The effect of mexiletine in comparison to placebo on extrasystole at rest and under strain].
Topics: Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Electrocardiography; Female; Hu | 1978 |
[Clinical value of computer-assisted arrhythmia analysis].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Computers | 1978 |
[Treatment of ventricular extrasystole with mexiletine and Neo-gilurytmal in myocardial infarct patients].
Topics: Adult; Aged; Ajmaline; Cardiac Complexes, Premature; Clinical Trials as Topic; Electrocardiography; | 1978 |
Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate.
Topics: Cardiac Complexes, Premature; Disopyramide; Electrocardiography, Ambulatory; Female; Heart Rate; Hum | 1992 |
[Long-term mexiletine treatment of ventricular arrhythmia in patients after myocardial infarction].
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; F | 1992 |
[Use of an anti-arrhythmia drug mexicord in the treatment of ventricular extrasystole].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; | 1992 |
Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia.
Topics: Aged; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Exercise Test; Humans; Male; Me | 1990 |
[Comparison of the anti-arrhythmic effectiveness of ethacizine, ethmozine, cordarone, mexitil and ritmilen in elderly patients with ventricular extrasystole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Ventricl | 1990 |
A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
Topics: Cardiac Complexes, Premature; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; | 1991 |
[Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Conduct | 1991 |
Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Cardiomyop | 1991 |
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Tria | 1985 |
[Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia].
Topics: Adult; Aged; Arrhythmias, Cardiac; Asthenia; Cardiac Complexes, Premature; Clinical Trials as Topic; | 1985 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Comple | 1985 |
Mexiletine: a new type I antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Biotransformation; Cardiac Complexes, Premature; Clinical Trials as | 1986 |
[Clinical study of the effectiveness and characteristics of the action of mexitil in the treatment of extrasystole in middle-aged and elderly patients].
Topics: Age Factors; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Dose-Response Relationshi | 1986 |
[Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electr | 1987 |
[Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Coronary | 1987 |
Chronic mexiletine therapy for suppression of ventricular arrhythmias.
Topics: Cardiac Complexes, Premature; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocar | 1988 |
[Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Dr | 1988 |
[Comparative study of the effectiveness of allapinin in patients with frequent and stable extrasystole].
Topics: Aconitine; Aconitum; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Tri | 1988 |
Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Chronic Disease; | 1989 |
[Comparative effectiveness of Na+ channel blockers in ventricular disorders of cardiac rhythm].
Topics: Adult; Aged; Calcium Channel Blockers; Cardiac Complexes, Premature; Clinical Trials as Topic; Disop | 1989 |
[Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)].
Topics: Adult; Aged; Biological Availability; Cardiac Complexes, Premature; Clinical Trials as Topic; Double | 1989 |
Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Double-Bl | 1985 |
48 other studies available for mexiletine and Cardiac Complex, Premature
| Article | Year |
|---|---|
Ventricular tachyarrhythmias in a canine model of LQT3: arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Dogs; Electrocardiography; Heart Rate | 2003 |
Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Topics: Animals; Arrhythmias, Cardiac; Asparagine; Cardiac Complexes, Premature; Long QT Syndrome; Mexiletin | 2007 |
[Decrease in the fast sodium inflow current, a possible reason for the anti-arrhythmic action of etmozin and mexityl in the late stage of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Dogs; Dose-Response Relationship, Dru | 1980 |
[Antiarrhythmic effect and influence on myocardial contractile function of the preparation, mexitil].
Topics: Adult; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Drug Evaluation | 1980 |
[Use of mexitil in ventricular arrhythmias].
Topics: Adult; Aged; Cardiac Complexes, Premature; Female; Humans; Male; Mexiletine; Middle Aged; Propylamin | 1981 |
[Prolonged treatment with oral mexiletine in severe ventricular extrasystole].
Topics: Adult; Aged; Cardiac Complexes, Premature; Chagas Cardiomyopathy; Female; Humans; Male; Mexiletine; | 1981 |
[Oral maintenance treatment with mexiletine after acute administration of xilocaine (author's transl)].
Topics: Administration, Oral; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Injections | 1981 |
[Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; M | 1981 |
[Effectiveness of mexiletine in arrhythmia of effort].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluati | 1981 |
[Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Child; Female; Heart Ventricles; Humans; Mexilet | 1982 |
[Anti-arrhythmic effects of mexiletine].
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography; | 1982 |
[Mexiletine in the treatment of arrhythmia].
Topics: Adolescent; Adult; Aged; Cardiac Complexes, Premature; Chemical Phenomena; Chemistry; Female; Follow | 1982 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
[Esophageal ulcer caused by mexiletine].
Topics: Aged; Cardiac Complexes, Premature; Esophageal Diseases; Female; Hemoptysis; Humans; Male; Mexiletin | 1983 |
[Injectable mexiletine and disorders of the auricular rhythm].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature; Female; Heart Atria | 1983 |
Well-controlled comparative study of the clinical effectiveness of intravenous mexiletine and procainamide on ventricular premature contraction.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiac Complexes, Premature; Electrocardiography; Female; | 1984 |
Carbamate analogues of tocainide.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Carbamates; C | 1994 |
Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Complexes, Premature; Coronary Disease; Dis | 1995 |
Haemodynamic studies on mexiletine, anew antiarrhythmic agent.
Topics: Cardiac Complexes, Premature; Female; Heart; Hemodynamics; Humans; Male; Mexiletine; Middle Aged; Pr | 1977 |
The development of mexiletine in the management of ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; Male; Mexileti | 1977 |
Antiarrhythmic and haemodynamic effects of mexiletine.
Topics: Adult; Blood Pressure; Cardiac Complexes, Premature; Cardiac Output; Female; Heart Ventricles; Hemod | 1977 |
[Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Human | 1977 |
The efficacy of intravenous mexiletine on ventricular ectopic activity.
Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Female; Heart Ventricles; | 1977 |
[Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; | 1979 |
Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; | 1992 |
Autonomic effects of antiarrhythmic drugs and their importance.
Topics: Adult; Autonomic Nervous System; Cardiac Complexes, Premature; Electrocardiography; Female; Flecaini | 1992 |
[A severe skin reaction following mexiletene].
Topics: Aged; Cardiac Complexes, Premature; Drug Eruptions; Humans; Male; Mexiletine | 1992 |
[Combination anti-arrhythmic drug therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electro | 1992 |
[The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma].
Topics: Aged; Aged, 80 and over; Asthma; Cardiac Complexes, Premature; Drug Interactions; Female; Humans; Ma | 1992 |
Efficacy of oral mexiletine therapy at a 12-h dosage interval.
Topics: Administration, Oral; Aged; Cardiac Complexes, Premature; Drug Administration Schedule; Electrocardi | 1990 |
Interaction between theophylline and mexiletine.
Topics: Aged; Asthma; Cardiac Complexes, Premature; Drug Interactions; Heart Block; Humans; Male; Mexiletine | 1990 |
[Evaluation of risks and treatment of asymptomatic ventricular arrhythmias].
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Female; | 1990 |
Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats.
Topics: Adult; Aged; Cardiac Complexes, Premature; Disopyramide; Dose-Response Relationship, Drug; Drug Admi | 1991 |
Clinical study on coupling interval of ventricular premature contraction in patients with organic heart disease.
Topics: Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography, Ambulatory; Femal | 1991 |
Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia.
Topics: Aged; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ele | 1991 |
[Mexiletine in the acute treatment of ventricular arrhythmias in cardiosurgery].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Surgical Procedures; Female | 1985 |
Effectiveness of mexiletine in ventricular arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography; Female; Heart | 1985 |
[Evaluation of the efficiency of mexiletine in ventricular extrasystole in the post-infarct stage].
Topics: Adult; Aged; Cardiac Complexes, Premature; Drug Administration Schedule; Female; Humans; Male; Mexil | 1987 |
[Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
Topics: Aged; Cardiac Complexes, Premature; Delayed-Action Preparations; Double-Blind Method; Female; Heart | 1987 |
[Therapeutic efficacy of mexiletine].
Topics: Adult; Aged; Aged, 80 and over; Cardiac Complexes, Premature; Female; Humans; Male; Mexiletine; Midd | 1987 |
Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
Topics: Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Cardiac Complexes, Premature; Disopyramide; Guin | 1988 |
[Treatment with mexiletine. Clinical and pharmacokinetic studies].
Topics: Adult; Aged; Aged, 80 and over; Cardiac Complexes, Premature; Electrocardiography; Humans; Infusions | 1988 |
[The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Evaluation; Drug Therap | 1988 |
[Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug E | 1988 |
Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combinatio | 1988 |
Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disopyram | 1989 |
Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Dru | 1985 |
Evaluation of antiarrhythmic drug efficacy using holter electrocardiographic technique.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, | 1985 |